Drug Shortage Report for SANDOZ CYCLOSPORINE
Report ID | 74753 |
Drug Identification Number | 02247073 |
Brand name | SANDOZ CYCLOSPORINE |
Common or Proper name | CYCLOSPORINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CYCLOSPORINE |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | L04AD |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-01-07 |
Estimated end date | 2019-06-03 |
Actual end date | 2019-05-28 |
Shortage status | Resolved |
Updated date | 2019-05-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-02-04 | English | Compare |
v2 | 2019-02-04 | French | Compare |
v3 | 2019-03-05 | English | Compare |
v4 | 2019-03-05 | French | Compare |
v5 | 2019-05-29 | English | Compare |
v6 | 2019-05-29 | French | Compare |
Showing 1 to 6 of 6